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Background: G protein-gated inwardly rectifying potassium (GIRK) channels are involved
in the regulation of neuronal excitability. Four GIRK subunits (GIRK1-4) are expressed in rat
dorsal root ganglia (DRGs). Recently, we have characterized the expression of GIRK1 and
−2, and both are downregulated in rat DRGs and spinal cord after a complete sciatic nerve
transection (axotomy). Here, we aimed to study the neurochemical characteristics of GIRK3,
and its regulation in rat DRGs and spinal cord induced by nerve injury.
Methods: A sciatic nerve axotomy was performed to study the influences of injury on
GIRK3 expression in DRGs and spinal cord. A dorsal root rhizotomy and a sciatic nerve
crush were employed to study the axonal transport of GIRK3 protein, respectively.
Immunohistochemistry analysis was employed for investigating the neurochemical charac-
teristics of GIRK3.
Results: In control DRGs, ~18% of neuron profiles (NPs) were GIRK3-positive (+), and
~41%, ~48% and ~45% of GIRK3+ NPs were CGRP+, IB4+ and NF200+, respectively.
GIRK3-like immunoreactivity was observed in glabrous skin of hind paws and axons
originating from DRG neurons. Fourteen days after axotomy, more than one-third of DRG
NPs were GIRK3+, and among these ~51% and ~56% coexpressed galanin and neuropeptide
Y, respectively. In control animals, a small group of interneurons found in the dorsal horn
was GIRK3+. In addition, GIRK3+ processes could be observed in superficial laminae of
spinal dorsal horn. After nerve injury, the intensity of GIRK3-like immunoreactivity in the
superficial layers was increased. Evidence based on rhizotomy and sciatic nerve crush
indicated both anterograde and retrograde transport of GIRK3.
Conclusion: Our study demonstrates that GIRK3 is expressed in sensory neurons and spinal
cord. GIRK3 has both anterograde and retrograde axonal transport. GIRK3 expression can be
regulated by peripheral nerve injury.
Keywords: GIRK channels, Kir3, axotomy, DRGs, spinal cord, chronic pain
Introduction
Inhibitory (Gi/o) G protein-coupled receptor signaling pathways regulate membrane
excitability in many cell types, including neurons, endocrine cells and cardiac
myocytes.1 G protein-gated inwardly rectifying potassium (GIRK) channels are
common downstream effectors for PTX-sensitive Gi/o-dependent signaling path-
ways in the nervous system.2 The mechanisms underlying activation of GIRK
channels have been explored and evidence shows that GIRK channels are activated
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receptors.3,4 A well-established example is opioid-induced
analgesia which involves GIRK channels acting as down-
stream effectors.5–8 In addition, GIRK channels are known
to mediate the inhibitory effects of many other neurotrans-
mitters and drugs of abuse.9,10 GIRK channel subunits
have been detected in dorsal root ganglion (DRG) neurons
of rats and humans,11–14 and mice.15,16 Opiates are known
to be highly effective in acute pain and acute inflammatory
pain,17–21 but are less effective in neuropathic pain patients
or animal models. After peripheral nerve injury, the
GIRK1 and −2 proteins are significantly downregulated
in DRGs and spinal dorsal horn.22 This suggests
a possible loss of opioid-induced inhibition.
There are four GIRK subunits (GIRK1-4) in mammals, of
which GIRK1 and −2 have splice variants, but not GIRK3 or
GIRK4.23 Functional GIRK channels are composed of
homotetramers or heterotetramers. GIRK3 cannot form func-
tional homotetramers24 but rather assembles with other
GIRK subunits to form functional channels. In addition,
GIRK3 is suggested to regulate GIRK signaling differently
from other GIRK subunits based on the findings that in
GIRK2- and/or 1-knockout (KO) mice, a strong reduction
of GIRK current is detected in the brain,25 however, GIRK3-
KO mice exhibit similar currents induced by agonist but less
severe sedatives induced withdrawal as compared to wild-
type (WT) mice.26 In GIRK2-KO mice, massive behavioral
abnormalities have been found, whereas GIRK3-KO mice
are no different from WT mice in behavioral tests.1,27,28
Moreover, a lysosomal targeting sequence in GIRK3 can
promote the degeneration of GIRK channels.29 All evidence
above points out the significance of GIRK3 for GIRK chan-
nel function, which is different from other GIRK subunits.
Recently, the expression of GIRK1 and GIRK2 has been
studied in rat lumbar (L) DRGs and spinal cord, and both
subunits are downregulated by peripheral axotomy.22 In this
study, the effects of nerve injury on GIRK3 expression were
investigated in DRGs and spinal cord, and the axonal trans-
port of GIRK3 was also analyzed.
Materials and Methods
Animals
Adult male Sprague–Dawley rats (200–250 g, B&K
Universal, Stockholm, Sweden) were used in this study. The
rats were housed 2 or 3 per cage and allowed to access to food
andwater ad libitum. All experiments were performed accord-
ing to the Ethical Guidelines of the International Association
for the Study of Pain and were approved by the local research
ethics committee (Stockholm’s Norra Djurförsöksetiska
Nämnd (N150/11)).
Surgical Procedures
The surgery for a unilateral complete sciatic nerve transection
(axotomy) was made according to a previous study.30 The rats
subjected to axotomy were allowed to survive for 14 days.
Dorsal root rhizotomy and sciatic nerve crush were performed
according to previous procedures.31,32 Briefly, both skin and
muscles were incised to expose vertebral laminae under deep
anesthesia, followed by transection of L2-5 dorsal roots, and
finally muscles and skin were sutured. The rats subjected to
rhizotomy were allowed to survive for 14 days. The rats sub-
jected to sciatic nerve crush were sacrificed 10 hrs postsurgery.
Immunohistochemistry
All rats were deeply anesthetized with sodium pentobarbi-
tal (50 mg/kg, i.p.). The anaesthetic animals were transcar-
dially perfused with 50 mL warm saline (0.9%; 37°C),
followed by 50 mL 4% paraformaldehyde, and finally by
250 mL of the same, but ice-cold fixative. The contra- and
ipsilateral DRGs (L4-5), as well as corresponding spinal
cord at injured levels, were dissected out and post-fixed in
the fixative for 90 min at 4°C. Subsequently, all specimens
were stored in 10% sucrose at 4°C for 2 days. Tissues
were embedded in OCT compound (Tissue Tek, Sakura,
Leiden, Netherland), and then sectioned in a cryostat
(Microm, Heidelberg, Germany) at 12 μm (DRGs) or 14
μm (hind paw skin and sciatic nerve), and 20 μm (spinal
cord) thickness. Immunoreactivities were visualized by
tyramide signal amplification system (TSA Plus; NEN
Life Science Products, Boston, MA) as described
previously.33 To perform colocalization study in DRG
sections, adjacent ones (5 μm) were used for staining
with different primary antibodies. In spinal cord, sciatic
nerve or skin of hind paws, TSA Plus staining was per-
formed, followed by indirect immunohistochemistry,34
visualized by lissamine rhodamine sulfonylchloride-
conjugated donkey anti-rabbit or mouse antibodies
(1:100; Jackson Immuno Research, West Grove, PA,
USA). Information for primary antibodies used in this
study was provided in Table 1.
The specificity of anti-GIRK3 polyclonal antibody was
confirmed by immunohistochemistry using brain samples
from GIRK3-KO mice.35 To detect IB4-binding neurons,
the sections were incubated with isolectin B4 (IB4)
(Griffonia simplicifolia I, 2.5 g/mL; Vector Laboratories,
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Burlingame, CA), followed by incubation with a goat anti-
GSA I antiserum (1:2,000; Vector Laboratories).
Western Blot
On day 14 following axotomy, the contra- and ipsilateral
DRGs (L4-5) were respectively collected, and then immedi-
ately snap frozen on dry ice. The tissues were roughly broken
with knife and placed in lysis buffer containing protease
inhibitor (P8340; Sigma), followed by sonication. The lysates
were centrifuged for 30 min under 10,000×g at 4 °C, and the
supernatants were used for Western blot analysis according to
our previous procedures.22 Briefly, 20 μg of protein was
loaded on 10% SDS-PAGE gel and transferred to polyvinyli-
dene fluoride membrane (Millipore, Hemel, Hempstead, UK).
The anti-GIRK3 polyclonal antibody used in this study is
known to recognize a protein of ~45 kD protein in WT
cerebellum, but absent in either GIRK3-KO or GIRK2/3-KO
mice.35 The β-actin was used as a loading control.
Image Analysis and Quantification
The sections were analysed in a confocal scanning micro-
scope (Bio-Rad, Hemel, Hempstead, UK) equipped with ×10
(0.5 NA), ×20 (0.75 NA) and ×63 oil (1.40 NA) objectives.
In some experiments, a LSM 700 confocal microscope
(Zeiss, Oberkochen, Germany) was used as described in
previous studies.33,36 The quantification was performed fol-
lowing the same set as in a previous report.22
Statistical Analysis
The statistical results were expressed as mean ± SEM.
Percentages of GIRK3 immunoreactive (-IR) neuron pro-
files (NPs) were evaluated by unpaired Student’s t-test
between contra- and ipsilateral DRGs. The band intensity
in Western blot and fluorescence levels for GIRK3-like
immunoreactivity (LI) in proximal and distal sciatic
nerve was performed by densitometry with Image
J software.
Results
Expression of GIRK3 in Control DRGs
In this study, the immunofluorescent signal of GIRK3 was
observed in rat DRGs but was undetectable when the anti-
GIRK3 antibody was pre-incubated with the homologous
antigen in an absorption test (Figure 1A vs. D). High
power immunofluorescence micrographs showed that the
GIRK3-LI was largely accumulated in a punctate pattern
in the cytoplasm surrounding the nucleus (Figure 1C).
Based on previously described classification principle,
DRG neurons were grouped into three subpopulations using
neuronalmarkers calcitonin gene-related peptide (CGRP), IB4
and neurofilament 200 (NF200).37 CGRP, IB4 and NF200
were used to label small peptidergic, small non-peptidergic,
and medium-sized and large myelinated neurons, respectively.
GIRK3-LI was detected in peptidergic and non-peptidergic
NPs with a broad size spectrum, including small, medium-
sized and large ones (Figure 1A, B and E–M). Quantification
results showed ~41%, ~48% and ~45% of GIRK3-IR NPs
expressed CGRP, IB4 and NF200, respectively. Conversely,
~38%, 54% and ~44% CGRP-IR, IB4-IR and NF200-IR NPs
expressed GIRK3, respectively (Figure 1N).
GIRK3 in Hind Paws and Sciatic Nerve
In rat glabrous skin of hind paws, GIRK3-LI was seen within
the dermis layer (Figure 2A–C2). GIRK3-LI co-localized with
CGRP and PGP9.5 in nerve terminals (Figure 2A–C2, D–F).
GIRK3-LI was intensively expressed in the nerve bundles, as
well as epineurium in the dermal layer of the hind paw skin
(Figure 2G–I). In addition, GIRK3-LI was also observed in
non-neuronal cells (Figure 2A2–C2). GIRK3was expressed in
Table 1 Primary Antibody List
Antibody Host Species Experiment Dilution Supplier/Catalogue No. Characterization
GIRK3 Rabbit IHC (TSA) 1:5,000 Professor M. Watanabe Aguado et al35
GIRK3 Rabbit IHC (Coons) 1:1,000 Professor M. Watanabe Aguado et al35
GIRK3 Rabbit WB 1:400 Professor M. Watanabe Aguado et al35
CGRP Rabbit IHC (Coons) 1:2,000 S.I. Grigis Orazzo et al46
NF200 Mouse IHC (Coons) 1:400 Sigma/N0142 Perry et al47
Gal Rabbit IHC (Coons) 1:4,000 E. Theodorsson Perry et al47
NPY Rabbit IHC (Coons) 1:400 Walsh and Wong Shi et al41
PGP9.5 Rabbit IHC (Coons) 1:400 Swant/PV 25 Brumovsky et al48
β-actin Mouse WB 1:5000 Sigma/A5441 Lyu et al22
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intact sciatic nerve and co-localized with CGRP, IB4 and
PGP9.5, respectively (Figure 3).
Upregulation of GIRK3 in Axotomized
DRGs
On day 14 following axotomy, a significant upregulation
in the percentage of GIRK3-IR NPs was observed in
injured DRGs (ipsi vs. contra; 38.5 ± 0.9% vs. 17.1 ±
0.8%; ***p < 0.001, n = 5) (Figure 4A–C). The relative
levels of GIRK3 were also confirmed to be upregulated in
the ipsilateral as compared to contralateral DRGs (from
two rats, the same side of DRGs was pooled) by Western
blot (Figure 4D). Of note, only one strong band with
predicted molecular weight was observed in the intact
Figure 1 GIRK3 co-localizes with neuronal markers in control DRGs. (A, B) Arrows indicate the neurons expressing GIRK3 (A) and CGRP (B). (C) High magnification
immunofluorescence micrograph shows punctate distribution of GIRK3-LI in the cytoplasm surrounding the nucleus. The dashed line indicates cellular border. The asterisk
indicates nucleus. (D) GIRK3+ signal is absent after pre-incubation of the antibodies with 10−6 M immunogen in the absorption test. (E–M) GIRK3-LI (E, H, K) co-localizes
with CGRP (F), IB4 (I) and NF200 (L) indicated by the arrows, respectively. (G), (J) and (M) are merged images. (N) Pie-graphs show the proportion of co-localization of
GIRK3 with each marker in control DRGs. The labeled number indicates counted NPs. Scale bars indicate 100 μm (A, B), 50 μm (E–M) and 20 μm (C, D).
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membrane for Western blot, further confirming the anti-
body specificity (Figure 4D).
The 29-amino acid neuropeptide (30 in humans) galanin
(Gal) and the 36-amino acid neuropeptide Y (NPY) are often
used as indicators of nerve injury-associated outcomes.
Under normal condition, NPY is usually undetectable in rat
DRGs but its mRNA and protein levels are dramatically
increased, predominantly in medium-sized and large NPs,
after peripheral nerve injury.38–41 Gal is expressed in a small
portion (<5%) of DRG NPs, but is strongly upregulated (up
to 50%) in injured DRGs, with peak levels on 7–14 days
after axotomy, at both mRNA and protein levels.42,43 In the
present study, ~56% and ~51% of GIRK3-positive (+) NPs
co-expressed NPY and Gal 14 days after axotomy, respec-
tively (Figure 4E–K). Conversely, ~85% of NPY+ and ~49%
of Gal+ NPs were GIRK3+, respectively (Figure 4E–K).
Peripheral Nerve Injury Induced an
Upregulation of GIRK3 in Spinal Dorsal
Horn
GIRK3-LI was mainly observed in the superficial layers of
dorsal horn (Figure 5A, D and I). The GIRK3-LI was
absent in the absorption test (Figure 5B). CGRP+ fibers
Figure 2 Characteristics of GIRK3 expression in skin of hind paw. (A–C) A large amount of GIRK3-LI (A) is seen in upper dermis, some co-localize with CGRP+ fibers (B).
(A1, B1, C1) High magnification of immunofluorescence micrographs shows the co-localized fibers of GIRK3-LI (A1; arrowheads) and CGRP-LI (B1; arrowheads). (A2,
B2, C2) Some GIRK3+ (A2; arrowheads), but CGRP− (B2; arrowheads) fibers are seen in the upper dermis. (D–F) GIRK3+ fibers (D; arrowheads) are also PGP9.5+ (E;
arrowheads) in upper dermis. (G–I) GIRK3-LI (G) co-localizes with PGP9.5-LI (H) largely in nerve bundles (white arrowheads) and epineurium (yellow arrowheads) in
lower dermis (I). Scale bars indicate 100 μm (A–C, G–I) and 20 μm (A1–C2, D–F).
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were found in lamina I and II with some extension to the
deeper laminae (Figure 5C). GIRK3-IR interneurons were
found in deeper laminae, but not superficial layers
(Figure 5D, E, G and H). These interneurons were CGRP-
negative (Figure 5F–H). An increase of GIRK3+ processes
was detected in the ipsilateral as compared with the con-
tralateral dorsal horn on day 14 after axotomy (Figure 5I).
Axonal Transport of GIRK3
Spinal dorsal rhizotomy was performed unilaterally.
After rhizotomy, CGRP-LI was largely reduced in the
ipsilateral dorsal horn as compared with contralateral
one (Figure 6A vs B). Similar to that of CGRP,
GIRK3+ signals were mostly eliminated in the ipsilateral
dorsal horn after rhizotomy, indicating an anterograde
transport of GIRK3 from peripheral sensory neurons to
central spinal cord (Figure 6C vs D). Sciatic nerve crush
caused an accumulation of GIRK3 at the injured site
where GIRK3-LI was significantly stronger in proximal
than distal sites (Figure 6E and F), thus indicating both
anterograde and retrograde transport of GIRK3 in DRG
neurons.
Discussion
We have recently investigated the expression and regulation of
GIRK1 and −2 in rat DRGs and spinal cord following periph-
eral nerve injury.22 In the present study, similar methods have
been employed to analyze the expression of GIRK3 in rat
DRGs and spinal cord. GIRK3 was expressed in ~17% of the
DRGNPs and significantly increased after axotomy (to around
39%). This contrasts with the expression of both GIRK1 and
−2, for which the corresponding proportions in controls were
~70% and <10%, respectively, and both were downregulated
(to ~55% and <2%, respectively). GIRK3 was also detected in
the spinal dorsal horn and also increased after axotomy.
Using RNA-seq, Flegel and colleagues investigated the
expression of G protein-coupled receptors and ion chan-
nels in human sensory ganglia, including DRGs and tri-
geminal ganglia.12 All GIRK channel subunits were found
in human DRGs, with a highest expression level of
GIRK1, lower expression levels of GIRK3 and GIRK4,
and lowest expression level of GIRK2. Our previously
published results22 and results presented in this study
reveal a similar expression pattern of GIRK1-3 in rats
compared to humans.
Figure 3 Expression of GIRK3-LI in sciatic nerve. (A–C) Double-staining shows a few GIRK3+ fibers (A) are CGRP+ (B) in sciatic nerve. (D–F) Some GIRK3+ fibers (D)
are IB4+ (E). (G–I) GIRK3-LI (G) in sciatic nerve shows co-localization with an axonal marker PGP9.5 (H). Arrowheads indicate the co-localization of GIRK3-LI with each
marker in sciatic nerve. (C), (F), and (I) are merged images. Scale bar indicates 20 μm (A–I).
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We further detected GIRK3-LI in all three major DRG
neuron subpopulations, which include neurons expressing
CGRP (small peptidergic), IB4 (small non-peptidergic) or
NF200 (medium-sized and large myelinated Aß), whereby
each of the three was found in 40~50% of the GIRK3+ NPs.
This means that there is a certain overlap, but the details still
need to be sorted out. Moreover, and importantly, also GIRK1
coexpressed these three markers with the following percen-
tages: ~17%, ~51% and ~39%.22 This indicates a potential for
interaction of GIRK3 with GIRK1 to form heterotetramer
channels in the subpopulations of DRG neurons. In contrast,
none of the GIRK2+ neurons expressed CGRP, but a high
percentage IB4 (~73%) and a lower percentage NF200
(~32%).22 Thus, our findings suggest a possible interaction
Figure 4 GIRK3 is upregulated in DRGs 14 days after axotomy. (A, B) Immunofluorescence micrographs show GIRK3-LI in contra- and ipsilateral DRGs, respectively. (C)
Quantification analysis shows percentage of GIRK3+ NPs is significantly higher in ipsilateral compared to contralateral DRGs after axotomy (n = 5 per group; ***p < 0.001).
(D) Western blot shows total protein of GIRK3 in DRGs is upregulated after axotomy. (E–G) GIRK3 (E) co-localizes with NPY (F) shown by arrows in ipsilateral DRGs.
(H–J) GIRK3 (H) co-localizes with Gal (I) shown by arrows in ipsilateral DRGs. (G) and (J) are merged images. (K) Pie-graphs show the proportion of DRG neurons
exhibiting co-localization of GIRK3 with NPY and Gal in ipsilateral DRGs, respectively. The labeled numbers indicate counted NPs. Arrows indicate co-localized neurons in
(E–J). Scale bars indicate 40 μm (A, B) and 50 μm (E–J).
Dovepress Lyu et al
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between GIRK3 and GIRK2 in non-peptidergic and myeli-
nated neurons. We found a large amount of GIRK3-LI sur-
rounding the nucleus in the cytoplasm without clear
membrane localization. This maybe because that GIRK3
lacks an endoplasmic reticulum (ER) export signal29 and
therefore it is retained in the ER after translation. In addition,
GIRK1 but not GIRK2 or 4 also lacks an ER export signal.
Thus, the GIRK1 is mostly not seen on the membrane.22
GIRK3+ processes were seen in the superficial layers of
spinal dorsal horn, especially in the lamina II. Interestingly,
GIRK1+ andGIRK2+ processeswere also found abundantly in
the lamina II. However, only accountable GIRK3+ interneur-
ons were seen in the deeper spinal dorsal horn laminae. Thus,
most of GIRK3+ fibers in the dorsal horn presumably originate
in DRGs. This is supported by our findings (i) sciatic nerve
crush causes an accumulation of GIRK3 on proximal side
indicating the existence of anterograde fast axonal transport;
and, especially, (ii) GIRK3-LI was completely eliminated in
the ipsilateral dorsal horn after dorsal root rhizotomy. Thus, the
majority of GIRK3 is located in the presynaptic terminals of
Figure 5 Expression and regulation of GIRK3 in spinal cord. GIRK3-LI is present in control dorsal horn (A), and is absent after pre-incubation of the antibody with 10−6
M immunogen in the absorption test (B). (C, D) GIRK3-LI (D) is largely localized in the superficial laminae but much weaker than CGRP-LI (C), and also present in a few
interneurons in deeper laminae (E, G, H). Representative micrographs show GIRK3+ (G and H; arrows) but CGRP− (F; arrows) interneurons in deeper laminae (GIRK3,
green; CGRP, red). (I) Fourteen days after axotomy, a dramatic upregulation of GIRK3-LI (red arrows) is seen on the ipsilateral (ipsi) as compared to contralateral (contra)
spinal dorsal horn. Scale bars indicate 500 μm (I), 100 μm (A–D), 50 μm (F–H) and 25 μm (E).
Figure 6 Axonal transport of GIRK3. (A–D) Fourteen days after unilateral dorsal rhizotomy, both CGRP- and GIRK3-LIs are largely decreased (red arrows) in ipsilateral
dorsal horn compared to contralateral one. (E, F) Ten hours after sciatic nerve crush (red arrows indicate injured site), significant more GIRK3-LI is accumulated on the
proximal side of the crush (green arrows) than the distal side (n = 3; **p < 0.01). Scale bars indicate 100 μm (A–D) and 50 μm (E).
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sensory input to the spinal cord, indicating a role inmodulating
spinal nociceptive processing at the presynaptic level. In con-
trast, much more GIRK1 and −2 LIs were detected in local
dorsal horn neurons. Moreover, both GIRK1 and −2 are axon-
ally transported,22 and they are also present in afferent nerve
endings. These two subunits may thus have both presynaptic
actions as well as controlling signalling in postsynaptic dorsal
horn interneurons.
It has been demonstrated that several types of potassium
(K+) channel-components are downregulated by peripheral
nerve injury in somatosensory system, including voltage-
gated K+ channels, two-pore-domain K+ channels, calcium2
+-activated K+ channels, ATP-sensitive K+ channels and
inwardly-rectifying K+ channels.2,44,45 The activation of
these K+ channels can induce K+ outflow and cause the
membrane potential of neurons more negative, which is
more inhibited. Here, we reported an upregulation of
GIRK3 in both DRGs and dorsal horn following peripheral
nerve injury, which is in contrast to the downregulation of
most of the other K+ channel-components as listed above.
These data reflect a unique and complex role of GIRK3 in
the sensory neurons. Considering a role of GIRK3 in redu-
cing the number of other GIRK channels on the cell surface
by targeting other subunits to lysosome for degradation,29
the upregulation of GIRK3 may be a possible reason for the
downregulation of GIRK1 and −2.
Gal andNPYare both strongly upregulated and have been
shown to be involved in nociceptive processing, especially
after peripheral nerve injury. Here, we observed that a high
proportion of GIRK3+ neurons contained Gal and NPY-LIs,
further supporting a role of GIRK3 in pain modulation.
Concluding Remarks
This work was an extension of our previous study on
GIRK1 and −2. Our aim was to investigate the expression
and regulation of GIRK3 in sensory neurons after nerve
injury. Together with our previously published data,
a summary of expression of GIRK channel subunits 1–3,
in rat DRGs and spinal dorsal horn, is as follows:
1. Of the three channel subunits, GIRK1 has the high-
est level of protein.
2. In contrast to the downregulation of GIRK1 and −2,
GIRK3-LI is upregulated after peripheral nerve injury.
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